Cognitive Multi-sensory Rehabilitation on Upper Limb Function and Fatigue in Stroke
Launched by CAIRO UNIVERSITY · Feb 1, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of therapy called Cognitive Multi-sensory Rehabilitation (CMR) to see how well it helps improve arm movement and reduce tiredness in people who have had a stroke. The main question is whether this new approach is better than traditional physical therapy for helping stroke patients regain their upper limb function and manage fatigue. Participants will be divided into two groups: one will receive CMR combined with physical therapy, while the other group will get only traditional physical therapy. Each person will attend 12 sessions over four weeks.
To be eligible for this study, participants need to be between 45 and 65 years old and have had an ischemic stroke at least 6 months but no more than 18 months ago. They should be living in the community, be medically stable, and score normally on a cognitive assessment. Participants can expect to engage in a structured program that includes both CMR and physical therapy. It's important to note that individuals with severe muscle stiffness or other significant medical issues may not qualify for this trial. If you're interested in participating, this study could provide a chance to explore new treatment options for improving arm function and reducing fatigue after a stroke.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 45 and 65 years.
- • 6-18 months after ischemic stroke
- • living in the community (i.e., not in a long-term care home).
- • medically stable.
- • normal score in the Montreal Cognitive Assessment (MoCA: 25 to 30, maximum score = 30).
- • Spasticity of upper limb muscles ranged from (grade 1:2) according to the Modified Ashworth scale.
- Exclusion Criteria:
- • severe spasticity (Modified Ashworth Scale score of 4)
- • any medical condition that hinders full participation,
- • another neurological diagnosis beyond stroke including cognitive impairment, or
- • upper extremity pain \> 4/10 on the Numeric Pain Rating Scale (maximum 10/10).
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza, Egypt
Patients applied
Trial Officials
Nahed Salem, professor
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported